Literature DB >> 33859262

Changes in the gene expression profile during spontaneous migraine attacks.

Lisette J A Kogelman1, Katrine Falkenberg2, Alfonso Buil3, Pau Erola4, Julie Courraud5, Susan Svane Laursen5, Tom Michoel6, Jes Olesen2, Thomas F Hansen7,8,9.   

Abstract

Migraine attacks are delimited, allowing investigation of changes during and outside attack. Gene expression fluctuates according to environmental and endogenous events and therefore, we hypothesized that changes in RNA expression during and outside a spontaneous migraine attack exist which are specific to migraine. Twenty-seven migraine patients were assessed during a spontaneous migraine attack, including headache characteristics and treatment effect. Blood samples were taken during attack, two hours after treatment, on a headache-free day and after a cold pressor test. RNA-Sequencing, genotyping, and steroid profiling were performed. RNA-Sequences were analyzed at gene level (differential expression analysis) and at network level, and genomic and transcriptomic data were integrated. We found 29 differentially expressed genes between 'attack' and 'after treatment', after subtracting non-migraine specific genes, that were functioning in fatty acid oxidation, signaling pathways and immune-related pathways. Network analysis revealed mechanisms affected by changes in gene interactions, e.g. 'ion transmembrane transport'. Integration of genomic and transcriptomic data revealed pathways related to sumatriptan treatment, i.e. '5HT1 type receptor mediated signaling pathway'. In conclusion, we uniquely investigated intra-individual changes in gene expression during a migraine attack. We revealed both genes and pathways potentially involved in the pathophysiology of migraine and/or migraine treatment.

Entities:  

Year:  2021        PMID: 33859262     DOI: 10.1038/s41598-021-87503-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  3 in total

1.  Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways.

Authors:  Zachary F Gerring; Joseph E Powell; Grant W Montgomery; Dale R Nyholt
Journal:  Cephalalgia       Date:  2017-01-06       Impact factor: 6.292

2.  The relationship between different fatty acids intake and frequency of migraine attacks.

Authors:  Omid Sadeghi; Zahra Maghsoudi; Fariborz Khorvash; Reza Ghiasvand; Gholamreza Askari
Journal:  Iran J Nurs Midwifery Res       Date:  2015 May-Jun

Review 3.  Molecular mechanisms of omega-3 fatty acids in the migraine headache.

Authors:  Neda Soveyd; Mina Abdolahi; Sama Bitarafan; Abbas Tafakhori; Payam Sarraf; Mansoureh Togha; Ali Asghar Okhovat; Mahsa Hatami; Mohsen Sedighiyan; Mahmoud Djalali; Niyaz Mohammadzadeh Honarvar
Journal:  Iran J Neurol       Date:  2017-10-07
  3 in total
  3 in total

Review 1.  Dural Immune Cells, CGRP, and Migraine.

Authors:  Louis K Balcziak; Andrew F Russo
Journal:  Front Neurol       Date:  2022-03-31       Impact factor: 4.086

2.  Citalopram Neuroendocrine Challenge Shows Altered Tryptophan and Kynurenine Metabolism in Migraine.

Authors:  Kinga Gecse; Andrea Edit Édes; Tamás Nagy; Adrienn Katalin Demeter; Dávid Virág; Márton Király; Borbála Dalmadi Kiss; Krisztina Ludányi; Zsuzsanna Környei; Adam Denes; Gyorgy Bagdy; Gabriella Juhasz
Journal:  Cells       Date:  2022-07-21       Impact factor: 7.666

Review 3.  New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach.

Authors:  Irene Simonetta; Renata Riolo; Federica Todaro; Antonino Tuttolomondo
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.